Overview

A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited)

Status:
Completed

Trial end date:
2019-08-03

Target enrollment:

Participant gender:

Summary

To Evaluate the Pharmacodynamic Equivalence of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg base (Sun Pharmaceuticals Industries Limited) to PROAIR® HFA (albuterol sulfate) Inhalation Aerosol, eq 90 mcg base (Teva Respiratory, LLC) in Subjects With Stable, Mild Asthma

Phase:

Phase 3

Details

Lead Sponsor:

Sun Pharmaceutical Industries Limited

Treatments:

Albuterol
Procaterol